Lupin Launches Formoflo-G for COPD Management in India
Lupin has launched Formoflo-G MDI, world's first fixed-dose triple combination of glycopyrronium, formoterol and fluticasone for moderate to severe COPD management.
Lupin COPD Inhaler | 06/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy